Literature DB >> 2235883

Absorption of polyethylene glycols 600 through 2000: the molecular weight dependence of gastrointestinal and nasal absorption.

M D Donovan1, G L Flynn, G L Amidon.   

Abstract

Polyethylene glycols (PEGs) 600, 1000, and 2000 were used to study the molecular weight permeability dependence in the rat nasal and gastrointestinal mucosa. Absorption of the PEGs was measured by following their urinary excretion over a 6-hr collection period. HPLC methods were used to separate and quantitate the individual oligomeric species present in the PEG samples. The permeabilities of both the gastrointestinal and the nasal mucosae exhibited similar molecular weight dependencies. The steepest absorption dependence for both mucosae occurs with the oligomers of PEG 600, where the extent of absorption decreases from approximately 60% to near 30% over a molecular weight range of less than 300 daltons. Differences in the absorption characteristics between the two sites appear in the molecular weight range spanned by PEG 1000. For these oligomers, the mean absorption from the nasal cavity is approximately 14%, while that from the gastrointestinal tract is only 9%. For PEG 2000, mean absorption decreases to 4% following intranasal application and below 2% following gastrointestinal administration. Within the PEG 1000 and 2000 samples, however, very little molecular weight dependency is seen among the oligomers. In the range studied, a distinct molecular weight cutoff was not apparent at either site.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2235883     DOI: 10.1023/a:1015921101465

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

1.  The absorption and excretion of a liquid polyethylene glycol.

Authors:  C B SHAFFER; F H CRITCHFIELD; J H NAIR
Journal:  J Am Pharm Assoc Am Pharm Assoc       Date:  1950-06

2.  Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to normal and abnormal permeability states in man and animals.

Authors:  V S Chadwick; S F Phillips; A F Hofmann
Journal:  Gastroenterology       Date:  1977-08       Impact factor: 22.682

3.  Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity.

Authors:  C McMartin; L E Hutchinson; R Hyde; G E Peters
Journal:  J Pharm Sci       Date:  1987-07       Impact factor: 3.534

4.  Nasal absorption of propranolol from different dosage forms by rats and dogs.

Authors:  A Hussain; S Hirai; R Bawarshi
Journal:  J Pharm Sci       Date:  1980-12       Impact factor: 3.534

5.  Estimation of polyethyleneglycols in human urine for studies of intestinal absorption.

Authors:  R W Baker; J Ferrett
Journal:  J Chromatogr       Date:  1983-04-08

6.  Lipophilicity, molecular weight, and drug action: reexamination of parabolic and bilinear models.

Authors:  E J Lien; P H Wang
Journal:  J Pharm Sci       Date:  1980-06       Impact factor: 3.534

7.  Polyethylene glycol 900 permeability of rat intestinal and colonic segments in vivo and brush border membrane vesicles in vitro.

Authors:  D Hollander; S Koyama; V Dadufalza; D Q Tran; P Krugliak; T Ma; K Y Ling
Journal:  J Lab Clin Med       Date:  1989-04

8.  Passage of molecules through the wall of the gastrointestinal tract. Intestinal permeability to polyethylene glycols in the 414- to 1,074-dalton range.

Authors:  C Tagesson; R Sjödahl
Journal:  Eur Surg Res       Date:  1984       Impact factor: 1.745

9.  A new micromethod for the quantification of low molecular weight oligomers of polyethylene glycol.

Authors:  H J McClung; P A Powers; H R Sloan; B Kerzner
Journal:  Clin Chim Acta       Date:  1983-11-15       Impact factor: 3.786

10.  Passage of molecules through the wall of the gastrointestinal tract. Measurement of intestinal permeability to polyethylene glycols in the 634-1338 dalton range (PEG 1000).

Authors:  C Tagesson; P A Andersson; T Andersson; T Bolin; M Källberg; R Sjödahl
Journal:  Scand J Gastroenterol       Date:  1983-05       Impact factor: 2.423

View more
  24 in total

1.  The molecular weight dependence of nasal absorption: the effect of absorption enhancers.

Authors:  M D Donovan; G L Flynn; G L Amidon
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

Review 2.  Delivering non-hormonal contraceptives to men: advances and obstacles.

Authors:  Dolores D Mruk; C Yan Cheng
Journal:  Trends Biotechnol       Date:  2008-01-11       Impact factor: 19.536

3.  Pharmacokinetic comparison between the long-term anesthetized, short-term anesthetized and conscious rat models in nasal drug delivery.

Authors:  Yin Cheong Wong; Shuai Qian; Zhong Zuo
Journal:  Pharm Res       Date:  2014-02-20       Impact factor: 4.200

4.  Intravital imaging of intestinal lacteals unveils lipid drainage through contractility.

Authors:  Kibaek Choe; Jeon Yeob Jang; Intae Park; Yeseul Kim; Soyeon Ahn; Dae-Young Park; Young-Kwon Hong; Kari Alitalo; Gou Young Koh; Pilhan Kim
Journal:  J Clin Invest       Date:  2015-10-05       Impact factor: 14.808

5.  In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery.

Authors:  C Witschi; R J Mrsny
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

6.  Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption.

Authors:  W Rubas; N Jezyk; G M Grass
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

7.  Insoluble powder formulation as an effective nasal drug delivery system.

Authors:  Fusashi Ishikawa; Mika Murano; Minoru Hiraishi; Toshikazu Yamaguchi; Ikumi Tamai; Akira Tsuji
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

8.  Enteral absorption of octreotide: absorption enhancement by polyoxyethylene-24-cholesterol ether.

Authors:  J Drewe; G Fricker; J Vonderscher; C Beglinger
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

9.  Mass balance approaches for estimating the intestinal absorption and metabolism of peptides and analogues: theoretical development and applications.

Authors:  P J Sinko; G D Leesman; G L Amidon
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

Review 10.  Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.

Authors:  Yeonhee Yun; Yong Woo Cho; Kinam Park
Journal:  Adv Drug Deliv Rev       Date:  2012-11-02       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.